Multimodal Detection of Subclinical Cardiovascular Disease in Chronic Kidney Disease
Cardiorenal Medicine · 31.08.2026 · 16 (1) · 476-487
DOI: 10.1159/crm/abtag004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiorenal Medicine, online erschienen am 31.08.2026. Verfasst von Inhae Baek und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Renal Insufficiency, Chronic, Multimodal Imaging. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background: Cardiovascular disease (CVD) is the leading cause of mortality among individuals with chronic kidney disease (CKD) and is driven by chronic inflammation, oxidative stress, vascular calcification, accumulation of uremic toxins, ventricular remodeling, and microvascular dysfunction. Subclinical CVD is highly prevalent in CKD and often remains unrecognized until advanced stages, contributing to delayed intervention and increased mortality. Summary: Early detection of subclinical CVD in CKD is critical to prevent disease progression and reduce adverse outcomes. Advances in noninvasive imaging modalities – including echocardiography, coronary computed tomography angiography, coronary artery calcium (CAC) scoring, and cardiac magnetic resonance imaging – enable sensitive identification of early cardiac and vascular abnormalities. In parallel, circulating and urinary biomarkers such as C-reactive protein, high-sensitivity troponin (hsT), N-terminal pro-brain natriuretic peptide, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), fibroblast growth factor-23, and urine albumin-to-creatinine ratio provide insight into underlying pathophysiological mechanisms and support risk stratification and personalized management. Key Messages: Subclinical CVD is common yet underdiagnosed in CKD, necessitating improved screening strategies. Integration of advanced imaging techniques with biomarker profiling offers a promising approach for early detection and individualized care. Continued innovation and implementation of these tools are essential to closing the cardiovascular mortality gap in this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Baek, I., Parwani, P., Gaznabi, S., Abramov, D., & Alani, A. (2026). Multimodal Detection of Subclinical Cardiovascular Disease in Chronic Kidney Disease. Cardiorenal Medicine, 16(1), 476-487. https://doi.org/10.1159/crm/abtag004
Vancouver
Baek I, Parwani P, Gaznabi S, Abramov D, Alani A. Multimodal Detection of Subclinical Cardiovascular Disease in Chronic Kidney Disease. Cardiorenal Medicine. 2026;16(1):476-487. doi:10.1159/crm/abtag004
BibTeX
@article{Baek2026,
author = {Baek, Inhae and Parwani, Purvi and Gaznabi, Safwan and Abramov, Dmitry and Alani, Anas},
title = {Multimodal Detection of Subclinical Cardiovascular Disease in Chronic Kidney Disease},
journal = {Cardiorenal Medicine},
year = {2026},
volume = {16},
number = {1},
pages = {476--487},
doi = {10.1159/crm/abtag004}
}
EUVIMED